Procainamide: Difference between revisions
(Created page with "== Adult Dosing == *Continuous infusion rate has fewer adverse effects **20-50mg/min for 25-30min ***Cont until arrhythmia is suppressed, hypotension, QRS >50% or max dose (17mg/...") |
|||
| Line 31: | Line 31: | ||
==See Also== | ==See Also== | ||
* | *[[Antiarrhythmics]] | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 21:38, 18 November 2011
Adult Dosing
- Continuous infusion rate has fewer adverse effects
- 20-50mg/min for 25-30min
- Cont until arrhythmia is suppressed, hypotension, QRS >50% or max dose (17mg/kg)
- If effective start cont infusion of 1-4mg/min
- 20-50mg/min for 25-30min
Contraindications
- Not recommended for V-fib or pulseless V-tach (too long to dose)
- 2nd or 3rd AV block
- Severe glycoside intoxication
- Prolonged QT
- Myasthenia gravis
Indications
- Wide-complex tachycardia of unknown type (in pts w/ preserved LV function)
- Stable V-tach
Mechanism of Action
- Class Ia
- Binds to fast Na channels in inactive state thereby inhibiting recovery after repolarization
- Prolongs action potential and reduces speed of impulse conduction
- Depresses myocardial conduction
- May act as negative inotrope, cause hypotension (peripheral vasodilation)
Adverse Drug Rxns
- Myocardial depression
- Watch for QRS/QT prolongation, V-tach, Vfib, complete AV block, torsades
Kinetics
- Onset of action = 5-10min
